S T A T E O F N E W Y O R K
________________________________________________________________________
5444--B
2025-2026 Regular Sessions
I N A S S E M B L Y
February 14, 2025
___________
Introduced by M. of A. ROSENTHAL -- read once and referred to the
Committee on Insurance -- committee discharged, bill amended, ordered
reprinted as amended and recommitted to said committee -- again
reported from said committee with amendments, ordered reprinted as
amended and recommitted to said committee
AN ACT to amend the insurance law, in relation to coverage for perimeno-
pausal and menopausal care and treatment
THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:
Section 1. Subsection (i) of section 3216 of the insurance law is
amended by adding a new paragraph 41 to read as follows:
(41) (A) EVERY POLICY THAT PROVIDES COVERAGE FOR HOSPITAL, SURGICAL OR
MEDICAL CARE SHALL PROVIDE COVERAGE FOR PERIMENOPAUSAL AND MENOPAUSAL
CARE AND TREATMENT ADMINISTERED BY A PHYSICIAN OR OTHER LICENSED HEALTH
CARE PROVIDER. SYMPTOMS OF MENSTRUAL COMPLICATIONS FOR PERIMENOPAUSAL
AND MENOPAUSAL CARE AUTHORIZED UNDER THIS PARAGRAPH INCLUDE, BUT ARE NOT
LIMITED TO: IRREGULAR MENSTRUAL PERIODS, TEMPORARY COGNITIVE CHANGES
RELATED TO THE MENOPAUSE TRANSITION, HOT FLASHES, CHILLS, SLOWED META-
BOLISM, VAGINAL OR BLADDER PROBLEMS, DECREASE IN FERTILITY, LOSS OF
BONE, INCREASE IN LOW-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS, AND SLEEP
DISRUPTION INCLUDING NIGHT SWEATS.
(B) FOR PURPOSES OF SUBPARAGRAPH (A) OF THIS PARAGRAPH:
(I) "MENOPAUSE" MEANS THE PERMANENT CESSATION OF OVULATION SO THAT
OVARIES STOP RELEASING FOLLICLES AND STOP PRODUCING ESTROGEN AND
PROGESTERONE. FOR WOMEN WITH AN INTACT UTERUS, MENOPAUSE IS MARKED BY A
TWELVE MONTH ABSENCE OF MENSTRUATION.
(II) "PERIMENOPAUSE" MEANS THE TRANSITION PERIOD FROM THE LATE REPRO-
DUCTIVE PHASE TO THE PERMANENT CESSATION OF OVARIAN FUNCTION WITH
ABSENCE OF MENSTRUATION.
EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD01048-07-5
A. 5444--B 2
(C) SUCH COVERAGE REQUIRED PURSUANT TO SUBPARAGRAPH (A) OF THIS PARA-
GRAPH SHALL NOT BE SUBJECT TO ANNUAL DEDUCTIBLES, CO-PAYMENT FEES OR
COINSURANCE.
§ 2. Subsection (k) of section 3221 of the insurance law is amended by
adding a new paragraph 24 to read as follows:
(24)(A) EVERY POLICY THAT PROVIDES COVERAGE FOR HOSPITAL, SURGICAL OR
MEDICAL CARE SHALL PROVIDE COVERAGE FOR PERIMENOPAUSAL AND MENOPAUSAL
CARE OR TREATMENT ADMINISTERED BY A PHYSICIAN OR OTHER LICENSED HEALTH
CARE PROVIDER. SYMPTOMS OF MENSTRUAL COMPLICATIONS FOR PERIMENOPAUSAL
AND MENOPAUSAL CARE AUTHORIZED UNDER THIS PARAGRAPH INCLUDE, BUT ARE NOT
LIMITED TO: IRREGULAR MENSTRUAL PERIODS, TEMPORARY COGNITIVE CHANGES
RELATED TO THE MENOPAUSE TRANSITION, HOT FLASHES, CHILLS, SLOWED META-
BOLISM, VAGINAL OR BLADDER PROBLEMS, DECREASE IN FERTILITY, LOSS OF
BONE, INCREASE IN LOW-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS, AND SLEEP
DISRUPTION INCLUDING NIGHT SWEATS.
(B) FOR PURPOSES OF SUBPARAGRAPH (A) OF THIS PARAGRAPH:
(I) "MENOPAUSE" MEANS THE PERMANENT CESSATION OF OVULATION SO THAT
OVARIES STOP RELEASING FOLLICLES AND STOP PRODUCING ESTROGEN AND
PROGESTERONE. FOR WOMEN WITH AN INTACT UTERUS, MENOPASUSE IS MARKED BY A
TWELVE MONTH ABSENCE OF MENSTRUATION.
(II) "PERIMENOPAUSE" MEANS THE TRANSITION PERIOD FROM THE LATE REPRO-
DUCTIVE PHASE TO THE PERMANENT CESSATION OF OVARIAN FUNCTION WITH
ABSENCE OF MENSTRUATION.
(C) SUCH COVERAGE REQUIRED PURSUANT TO SUBPARAGRAPH (A) OF THIS PARA-
GRAPH SHALL NOT BE SUBJECT TO ANNUAL DEDUCTIBLES, CO-PAYMENT FEES OR
COINSURANCE.
§ 3. Section 4303 of the insurance law is amended by adding a new
subsection (ww) to read as follows:
(WW)(1) ANY CONTRACT ISSUED BY A MEDICAL EXPENSE INDEMNITY CORPO-
RATION, A HOSPITAL SERVICE CORPORATION OR A HEALTH SERVICES CORPORATION
THAT PROVIDES COVERAGE FOR HOSPITAL, SURGICAL OR MEDICAL CARE SHALL
PROVIDE COVERAGE FOR PERIMENOPAUSAL AND MENOPAUSAL CARE OR TREATMENT
ADMINISTERED BY A PHYSICIAN OR OTHER LICENSED HEALTH CARE PROVIDER.
SYMPTOMS OF MENSTRUAL COMPLICATIONS FOR PERIMENOPAUSAL AND MENOPAUSAL
CARE AUTHORIZED UNDER THIS PARAGRAPH INCLUDE, BUT ARE NOT LIMITED TO:
IRREGULAR MENSTRUAL PERIODS, TEMPORARY COGNITIVE CHANGES RELATED TO THE
MENOPAUSE TRANSITION, HOT FLASHES, CHILLS, SLOWED METABOLISM, VAGINAL OR
BLADDER PROBLEMS, DECREASE IN FERTILITY, LOSS OF BONE, INCREASE IN LOW-
DENSITY LIPOPROTEIN CHOLESTEROL LEVELS, AND SLEEP DISRUPTION INCLUDING
NIGHT SWEATS.
(2) FOR PURPOSES OF PARAGRAPH ONE OF THIS SUBSECTION:
(A) "MENOPAUSE" MEANS THE PERMANENT CESSATION OF OVULATION SO THAT
OVARIES STOP RELEASING FOLLICLES AND STOP PRODUCING ESTROGEN AND
PROGESTERONE. FOR WOMEN WITH AN INTACT UTERUS, MENOPASUSE IS MARKED BY
A TWELVE MONTH ABSENCE OF MENSTRUATION.
(B) "PERIMENOPAUSE" MEANS THE TRANSITION PERIOD FROM THE LATE REPRO-
DUCTIVE PHASE TO THE PERMANENT CESSATION OF OVARIAN FUNCTION WITH
ABSENCE OF MENSTRUATION.
(3) SUCH COVERAGE REQUIRED PURSUANT TO PARAGRAPH ONE OF THIS
SUBSECTION SHALL NOT BE SUBJECT TO ANNUAL DEDUCTIBLES, CO-PAYMENT FEES
OR COINSURANCE.
§ 4. This act shall take effect on the first of January next succeed-
ing the date on which it shall have become a law and shall apply to
policies issued, reissued, renewed, modified or amended on or after such
date.